Philadelphia, PA6 Active Studies

B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Philadelphia, PA

Find 6 actively recruiting b-cell acute lymphoblastic leukemia clinical trials in Philadelphia, PA. Connect with local research sites and explore new treatment options.

6
Active Trials
4
Sponsors
623
Enrolling

Recruiting B-Cell Acute Lymphoblastic Leukemia Studies in Philadelphia

About B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Philadelphia

B-cell acute lymphoblastic leukemia (B-ALL) is a fast-growing cancer of the B-type lymphocyte white blood cells. It is the most common childhood cancer but can also occur in adults. Treatment includes chemotherapy, targeted therapy, and CAR-T cell therapy.

There are currently 6 b-cell acute lymphoblastic leukemia clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 623 participants. Research is being sponsored by Stephan Grupp MD PhD, Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Philadelphia — FAQ

Are there b-cell acute lymphoblastic leukemia clinical trials in Philadelphia?

Yes, there are 6 b-cell acute lymphoblastic leukemia clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What b-cell acute lymphoblastic leukemia treatments are being tested?

The 6 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for b-cell acute lymphoblastic leukemia.

Data updated October 16, 2026 from ClinicalTrials.gov